News

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
(Reuters) -Drugmaker Eli Lilly is in advanced talks to acquire gene-editing startup Verve Therapeutics for up to $1.3 billion ...
Hiltzik: With slate of anti-vaccine moves, RFK Jr. steps up his assault on public health
HHS Secretary Robert F. Kennedy Jr. places anti-vaxxers in control of U.S. vaccine policy, slandering an actual expert along ...